Category - Executive Moves

Executive Moves

Analysts start Quanterix at OP, buy; PTs $27, $26

Analysts at Leerink and BTIG launched coverage of Quanterix (NASDAQ:QTRX) with “outperform” and “buy” ratings, respectively, and price targets of $27 and $26, respectively. The stock closed at $21.47 on Dec. 29.

January 2, 2018

Executive Moves

Ortho RTi appoints Dr. Jacques Toueg to SAB

Ortho Regenerative Technologies (CSE:ORTH) appointed Dr. Jacques Toueg to its scientific advisory board (SAB).

December 19, 2017

Executive Moves

Rubius Therapeutics names Andrew Oh as CFO

Closely-held Rubius Therapeutics appointed Andrew Oh, who has more than 20 years of experience in finance and the biopharmaceutical industry, as CFO.

December 18, 2017

Executive Moves

Vital Therapies names Russell Cox as CEO

Vital Therapies (NASDAQ:VTL) has appointed Russell Cox as CEO and a member of the board, effective January 3, 2018.

December 5, 2017

Executive Moves

Jesse Ledger named CEO of Nuvo Pharma

Nuvo Pharmaceuticals (TSX:NRI) appointed Jesse Ledger as CEO, succeeding John London who continues as executive chairman and a director.

November 23, 2017

Executive Moves

Novelion Therapeutics CEO Mary Szela resigns

Novelion Therapeutics (NASDAQ:NVLN) CEO, Mary Szela, has resigned for personal reasons, effective immediately, and the company has begun a search for a new CEO.

November 9, 2017

Executive Moves

Jeffrey Kadanoff joins Synergy as CFO

Synergy CHC (OTCQB:SNYR) appointed Jeffrey Kadanoff as its CFO, effective Nov, 1, 2017.

October 16, 2017

Executive Moves

Tom Wright joins Ortho RTi board

Ortho Regenerative Technologies appointed global sports and entertainment veteran, Tom Wright, to the board.

October 3, 2017

Executive Moves

Roth expands healthcare research team

Dr. Jotin Marango and Yasmeen Rahimi have joined the healthcare research team at Roth Capital Partners.

September 20, 2017

Executive Moves

Ortho RTi CSO appointed bioengineering chair at George Mason

Ortho Regenerative Technologies said its chief scientific officer, Michael Buschmann, has been appointed as bioengineering chair, professor and eminent scholar (an award from Virginia’s Center for Innovative...

September 7, 2017

Category - Executive Moves

Subscribe